Abstract
Efficient gene transfer to hematopoietic stem cells by Moloney murine leukemia virus-derived retroviral vectors benefits from ex vivo culture and cytokine support. Both also increase the risks of apoptosis and differentiation among cells targeted for transduction. In an effort to maximize the retention of stem cell properties in target cells, we developed a transduction protocol with a focus on minimizing graft manipulation, cytokine stimulation, and ex vivo exposure duration. Based on their wide host range and ability to transduce quiescent cells, human immunodeficiency virus (HIV)-derived lentivirus vectors are ideally suited for this purpose. Our present studies in a murine model show that whole bone marrow cells are readily transduced after a 1-hour vector exposure in the presence of stem cell factor and CH296 fibronectin fragment. Using this rapid transduction protocol, we achieved long-term, multilineage reconstitution of murine recipients with up to 25% GFP-expressing cells in primary and secondary recipients. Our results demonstrate the unique ability of HIV-derived vectors to transduce hematopoietic stem cells in the absence of enrichment, under minimal cytokine stimulation, and following brief exposures.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gothot A, van der Loo JC, Clapp DW, Srour EF . Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic/severe combined immune-deficient mice. Blood 1998; 92: 2641–2649.
Kittler EL, Peters SO, Crittenden RB, Debatis ME, Ramshaw HS, Stewart FM et al. Cytokine-facilitated transduction leads to low-level engraftment in nonablated hosts. Blood 1997; 90: 865–872.
Mazurier F, Gan OI, McKenzie JL, Doedens M, Dick JE . Lentivector-mediated clonal tracking reveals intrinsic heterogeneity in the human hematopoietic stem cell compartment and culture-induced stem cell impairment. Blood 2004; 103: 545–552.
Takatoku M, Sellers S, Agricola BA, Metzger ME, Kato I, Donahue RE et al. Avoidance of stimulation improves engraftment of cultured and retrovirally transduced hematopoietic cells in primates. J Clin Invest 2001; 108: 447–455.
Carreau M, Gan OI, Liu L, Doedens M, Dick JE, Buchwald M . Hematopoietic compartment of Fanconi anemia group C null mice contains fewer lineage-negative CD34+ primitive hematopoietic cells and shows reduced reconstruction ability. Exp Hematol 1999; 27: 1667–1674.
Croop JM, Cooper R, Fernandez C, Graves V, Kreissman S, Hanenberg H et al. Mobilization and collection of peripheral blood CD34+ cells from patients with Fanconi anemia. Blood 2001; 98: 2917–2921.
Reiser J, Harmison G, Kluepfel-Stahl S, Brady RO, Karlsson S, Schubert M . Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles. Proc Natl Acad Sci USA 1996; 93: 15266–15271.
Kurre P, Anandakumar P, Harkey MA, Thomasson B, Kiem HP . Efficient marking of murine long-term repopulating stem cells targeting unseparated marrow cells at low lentiviral vector particle concentration. Mol Ther 2004; 9: 914–922.
Hanenberg H, Xiao XL, Dilloo D, Hashino K, Kato I, Williams DA . Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nat Med 1996; 2: 876–882.
Donahue RE, Sorrentino BP, Hawley RG, An DS, Chen IS, Wersto RP . Fibronectin fragment CH-296 inhibits apoptosis and enhances ex vivo gene transfer by murine retrovirus and human lentivirus vectors independent of viral tropism in nonhuman primate CD34+ cells. Mol Ther 2001; 3: 359–367.
O’Rourke JP, Newbound GC, Kohn DB, Olsen JC, Bunnell BA . Comparison of gene transfer efficiencies and gene expression levels achieved with equine infectious anemia virus- and human immunodeficiency virus type 1-derived lentivirus vectors. J Virol 2002; 76: 1510–1515.
Salmon P, Kindler V, Ducrey O, Chapuis B, Zubler RH, Trono D . High-level transgene expression in human hematopoietic progenitors and differentiated blood lineages after transduction with improved lentiviral vectors. Blood 2000; 96: 3392–3398.
Kurre P, Anandakumar P, Harkey M, Kiem H-P . Multi-copy integration after HIV-derived lentivirus vector transduction of murine hematopoietic stem cells does not promote clonal proliferation in primary or secondary recipients. Proceedings of the 46th Annual Meeting of the American Society of Hematology; 2004; San Diego, USA. American Society of Hematology: San Diego, USA, p a2105.
Kustikova OS, Wahlers A, Kuhlcke K, Stahle B, Zander AR, Baum C et al. Dose finding with retroviral vectors: correlation of retroviral vector copy numbers in single cells with gene transfer efficiency in a cell population. Blood 2003; 102: 3934–3937.
Li Z, Schwieger M, Lange C, Kraunus J, Sun H, van den Akker E et al. Predictable and efficient retroviral gene transfer into murine bone marrow repopulating cells using a defined vector dose. Exp Hematol 2003; 31: 1206–1214.
Woods NB, Muessig A, Schmidt M, Flygare J, Olsson K, Salmon P et al. Lentiviral vector transduction of NOD/SCID repopulating cells results in multiple vector integrations per transduced cell: risk of insertional mutagenesis. Blood 2003; 101: 1284–1289.
Mostoslavsky G, Kotton DN, Fabian AJ, Gray JT, Lee J-sS, Mulligan RC . Efficiency of transduction of highly purified murine hematopoietic stem cells by lentiviral and oncoretroviral vectors under condiitions of minimal manipulation. Mol Ther 2005; 11 (6): 932–940.
Blomer U, Gruh I, Witschel H, Haverich A, Martin U . Shuttle of lentiviral vectors via transplanted cells in vivo. Gene Therapy 2005; 12: 67–74.
DePolo NJ, Reed JD, Sheridan PL, Townsend K, Sauter SL, Jolly DJ et al. VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum. Mol Ther 2000; 2: 218–222.
Kaplan AH, Swanstrom R . The HIV-1 gag precursor is processed via two pathways: implications for cytotoxicity. Biomed Biochim Acta 1991; 50: 647–653.
Li X, Le Beau MM, Ciccone S, Yang FC, Freie B, Chen S et al. Ex vivo culture of Fancc−/− stem/progenitor cells predisposes cells to undergo apoptosis and surviving stem/progenitor cells display cytogenetic abnormalities and an increased risk of malignancy. Blood 2005; 105: 3465–3471.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on Gene Therapy website (http://www.nature.com/gt).
Supplementary information
Rights and permissions
About this article
Cite this article
Kurre, P., Anandakumar, P. & Kiem, HP. Rapid 1-hour transduction of whole bone marrow leads to long-term repopulation of murine recipients with lentivirus-modified hematopoietic stem cells. Gene Ther 13, 369–373 (2006). https://doi.org/10.1038/sj.gt.3302659
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3302659
Keywords
This article is cited by
-
DNA Transfection of Bone Marrow Stromal Cells Using Microbubble-Mediated Ultrasound and Polyethylenimine: An In Vitro Study
Cell Biochemistry and Biophysics (2013)
-
SLAM-enriched hematopoietic stem cells maintain long-term repopulating capacity after lentiviral transduction using an abbreviated protocol
Gene Therapy (2010)
-
Genetic Correction of Hematopoiesis in Fanconi Anemia: The Case for a Non-HSC-Autonomous Defect
Molecular Therapy (2009)
-
Lentiviral-mediated Genetic Correction of Hematopoietic and Mesenchymal Progenitor Cells From Fanconi Anemia Patients
Molecular Therapy (2009)
-
Rapid Lentiviral Transduction Preserves the Engraftment Potential of Fanca−/− Hematopoietic Stem Cells
Molecular Therapy (2008)